Y4J-26635-92044
4 vaccinations
8 coded responses
35 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 010 / MA
- Registered
- 2021-10-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Dose 1 — Janssen/Johnson & Johnson
-
2021-10-25
Registered in v-safe
-
2021-10-25
Dose 2 — Moderna
-
2021-10-25
Survey response — day 0, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Bruising around injection site, but no aching and no pain when touch.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-27
-
2021-10-28
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Continue to have bruise around injection area. But no pain to the touch.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Bruise continues at injection area but no pain or pain to the touch.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-31
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Continuing bruise at injection site but no pain in area or to the touch.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Survey response — day 7, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Bruise continues at injection site but no pain and no pain to the touch.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2022-01-24
-
2022-04-19
Dose 3 — Moderna
- 2022-04-26
- 2022-05-05
- 2022-05-10
- 2022-05-17
- 2022-05-24
- 2022-06-01
- 2022-07-20
-
2022-09-19
Dose 4 — Moderna
-
2022-09-19
Survey response — day 0, dose 4MedDRA: Injection site pain — Feeling: GoodFree text: Slight pain when touch injection site.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-20
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-10-03
- 2022-10-10
-
2022-10-17
Survey response — day 28, dose 4MedDRA: Fatigue, Influenza like illness — Feeling: GoodFree text: Had flu shot 6 days ago and felt fatigued with mild flu-like symptoms for several days.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-24
- 2022-11-01
- 2022-12-19
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Janssen/Johnson & Johnson | No |
| 2 | 2021-10-25 | Moderna | No |
| 3 | 2022-04-19 | Moderna | No |
| 4 | 2022-09-19 | Moderna | No |
Free text
Release 10 — day 0, dose 2
Systemic reaction (other): No
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Bruising around injection site, but no aching and no pain when touch.
Systemic reaction (other): Continue to have bruise around injection area. But no pain to the touch.
Systemic reaction (other): Bruise continues at injection area but no pain or pain to the touch.
Systemic reaction (other): Continuing bruise at injection site but no pain in area or to the touch.
Release 10 — day 7, dose 2
Systemic reaction (other): Bruise continues at injection site but no pain and no pain to the touch.
Release 12 — day 0, dose 4
Systemic reaction (other): Slight pain when touch injection site.
Release 12 — day 28, dose 4
Symptoms: Had flu shot 6 days ago and felt fatigued with mild flu-like symptoms for several days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release